1. Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma
   Trisha Wise-Draper et al, 2018, Translational Oncology CrossRef
2. NUP214 in Leukemia: It’s More than Transport
   Adélia Mendes et al, 2019, Cells CrossRef
3. PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
   Upasana Ray et al, 2023, Oncogene CrossRef
4. Prognostic role of DEK in human solid tumors: a meta-analysis
   Gang Liu et al, 2017, Oncotarget CrossRef
5. DEK modulates both expression and alternative splicing of cancer‑related genes
   Bin Liu et al, 2022, Oncology Reports CrossRef
6. The Art of War: harnessing the epigenome against cancer
   Jonathan Nye et al, 2018, F1000Research CrossRef
7. The potential role of DEK over-expression in the radiation response of head and neck cancer
   Hui Xiao et al, 2021, Radiation Medicine and Protection CrossRef
8. The nuclear DEK interactome supports multi‐functionality
   Eric A. Smith et al, 2018, Proteins: Structure, Function, and Bioinformatics CrossRef
9. Radiomics and Ki-67 index predict survival in clear cell renal cell carcinoma
   Tong Zhang et al, 2023, The British Journal of Radiology CrossRef
10. Long Non-Coding LEF1-AS1 Sponge miR-5100 Regulates Apoptosis and Autophagy in Gastric Cancer Cells via the miR-5100/DEK/AMPK-mTOR Axis
    Huimin Zhang et al, 2022, International Journal of Molecular Sciences CrossRef
11. A role for intracellular and extracellular DEK in regulating hematopoiesis
    Maegan L. Capitano et al, 2017, Current Opinion in Hematology CrossRef
12. Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis
    Guanying Luo et al, 2017, Oncotarget CrossRef